At the time of writing, Voyager Therapeutics Inc [VYGR] stock is trading at $6.83, down -0.15%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VYGR shares have gain 3.88% over the last week, with a monthly amount glided 17.35%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Voyager Therapeutics Inc [NASDAQ: VYGR] stock has seen the most recent analyst activity on October 16, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $15. Previously, Guggenheim started tracking the stock with Buy rating on March 26, 2024, and set its price target to $22. On March 19, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $30 on the stock. Citigroup started tracking the stock assigning a Buy rating and suggested a price target of $16 on March 07, 2024. Wells Fargo upgraded its rating to a Overweight but $14 remained the price target by the analyst firm on January 02, 2024. Truist started tracking with a Buy rating for this stock on May 10, 2023, and assigned it a price target of $18. In a note dated March 10, 2023, Oppenheimer initiated an Outperform rating and provided a target price of $14 on this stock.
For the past year, the stock price of Voyager Therapeutics Inc fluctuated between $5.71 and $11.72. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. Voyager Therapeutics Inc [NASDAQ: VYGR] shares were valued at $6.83 at the most recent close of the market. An investor can expect a potential return of 112.3% based on the average VYGR price forecast.
Analyzing the VYGR fundamentals
According to Voyager Therapeutics Inc [NASDAQ:VYGR], the company’s sales were 143.77M for trailing twelve months, which represents an 509.48% jump. Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at -0.05%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is -0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.64 points at the first support level, and at 6.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.98, and for the 2nd resistance point, it is at 7.14.
Ratios To Look Out For
It is important to note that Voyager Therapeutics Inc [NASDAQ:VYGR] has a current ratio of 9.51. As well, the Quick Ratio is 9.51, while the Cash Ratio is 1.9. Considering the valuation of this stock, the price to sales ratio is 2.59, the price to book ratio is 1.11 and price to earnings (TTM) ratio is 23.84.
Transactions by insiders
Recent insider trading involved Fahey Sandell Jacquelyn, Chief Legal Officer, that happened on Oct 02 ’24 when 5999.0 shares were sold. Officer, Fahey Sandell Jacquelyn completed a deal on Oct 02 ’24 to buy 5999.0 shares. Meanwhile, Chief Operating Officer Swartz Robin sold 1357.0 shares on Apr 02 ’24.
